Koers AXM Pharma, Inc. Other OTC
Aandelen
AXMP
US0024571095
Farmaceutische producten
Omzet * | - | Omzet 1 * | - | Marktkapitalisatie | 104K 97,25K |
---|---|---|---|---|---|
Nettowinst (verlies) * | - | Nettowinst (verlies) 1 * | - | EV/omzet * | - |
Nettoliquiditeiten * | - 0 | Nettoliquiditeiten 1 * | - 0 | EV/omzet 1 * | - |
K/w-verhouding * |
-
| K/w-verhouding 1 * |
-
| Werknemers | - |
Dividendrendement * |
-
| Dividendrendement 1 * |
-
| Vrij verhandelbaar | 99% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Linda L. Forster
CEO | Chief Executive Officer | 55 | 02-07-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Emmanuel Neossi
CHM | Chairman | - | 30-06-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+26,47% | 664 mld. | |
+25,51% | 567 mld. | |
-6,33% | 354 mld. | |
+19,35% | 330 mld. | |
+4,23% | 286 mld. | |
+13,43% | 234 mld. | |
+4,64% | 199 mld. | |
-10,27% | 196 mld. | |
-4,04% | 148 mld. |